Alzheimer’s Research UK, a CCNA Partner Organization, has joined pharmaceutical companies worldwide and the UK government to launch a $100M (USD) Dementia Discovery Fund. The purpose of the new fund, managed by the venture capital firm SV Life Sciences (SVLS), is to support:
“… innovative new drug development projects… with the aim of finding new treatments capable of altering the course of diseases such as Alzheimer’s and improving symptoms for people affected.”
Applications from international researchers and research groups will be welcome. Currently, there is no call for applications; we will keep you informed when the call comes via CCNA’s website, under “News and Events” and via mass email.
For more information about the Dementia Discovery Fund, go to: http://www.alzheimersresearchuk.org/100m-dementia-discovery-fund-launches-to-support-pioneering-research/ (Note, this content is available in English only).